Repligen Corporation (RGEN) financial statements (2021 and earlier)

Company profile

Business Address 41 SEYON STREET
WALTHAM, MA 02453
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments528513209196194190176
Cash and cash equivalents528513209196194190176
Receivables44434439363132
Inventory, net of allowances, customer advances and progress billings55525145424241
Inventory55525145424241
Prepaid expense3   1  
Deferred costs    0  
Other current assets1   1  
Other undisclosed current assets1114134245
Total current assets:642622316284276267253
Noncurrent Assets
Operating lease, right-of-use asset262520 
Property, plant and equipment48433835322924
Intangible assets, net (including goodwill)681685690459462464466
Goodwill468469470326327327327
Intangible assets, net (excluding goodwill)213216220133135137139
Other noncurrent assets0000022
Deferred tax assets, net44  
Other undisclosed noncurrent assets34416   
Total noncurrent assets:758757752514499495492
TOTAL ASSETS:1,4001,3791,068798775762745
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities45363223262720
Accounts payable111011101097
Accrued liabilities33262113161813
Debt43109105103102101
Other undisclosed current liabilities   3   
Total current liabilities:4839141130130130121
Noncurrent Liabilities
Long-term debt and lease obligation26025620    
Long-term debt, excluding current maturities233230     
Operating lease, liability272620 
Liabilities, other than long-term debt21026292625
Deferred tax liabilities, net25252121
Other liabilities2100455
Other undisclosed noncurrent liabilities30382817   
Total noncurrent liabilities:2922954843292625
Total liabilities:340334189173159156146
Stockholders' equity
Stockholders' equity attributable to parent1,0601,045879625616606599
Common stock1100000
Additional paid in capital1,0681,064893646643639635
Accumulated other comprehensive loss(15)(22)(15)(14)(12)(12)(11)
Retained earnings (accumulated deficit)621(8)(16)(21)(26)
Total stockholders' equity:1,0601,045879625616606599
TOTAL LIABILITIES AND EQUITY:1,4001,3791,068798775762745

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues69697161525048
Cost of revenue
(Cost of Goods and Services Sold)
(30)(31)(31)(27)(24)(22)(21)
Gross profit:39384034282727
Operating expenses(33)(30)(29)(23)(20)(19)(22)
Operating income:681111884
Nonoperating income (expense)(2)(6)(1)(1)(1)(1)1
Investment income, nonoperating2211111
Other nonoperating income (expense)(0)0(1)00(0)0
Interest and debt expense (6)(2)(2)(2)(2)(2)
Income (loss) from continuing operations before equity method investments, income taxes:4(4)89553
Other undisclosed income from continuing operations before income taxes 62222 
Income from continuing operations before income taxes:421011773
Income tax expense(1)(0)(2)(2)(1)(2)(1)
Net income available to common stockholders, diluted:4288653

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income:4288653
Comprehensive income:4288653
Other undisclosed comprehensive income (loss), net of tax, attributable to parent7(7)(1)(2)(0)(1)(5)
Comprehensive income (loss), net of tax, attributable to parent:10(5)7664(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: